Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
12/2012
12/19/2012CN102827289A Porcine circovirus type 2 Cap protein and thymosin alpha1 fusion protein and application
12/19/2012CN102827288A Acid-activated CSP targeted antimicrobial peptide and preparation method and applications thereof
12/19/2012CN102827287A Compositions and methods for diagnosing and treating cancer
12/19/2012CN102827286A Fusion protein of Exendin-4 and mutational human serum albumin, and preparation method of fusion protein
12/19/2012CN102827285A Mouse-specific anti-fertility polypeptide
12/19/2012CN102827277A Anti-human serum albumin single-chain antibody and method for connecting polypeptide drugs to carbon end thereof
12/19/2012CN102178950B Subunit vaccine immunologic adjuvant and application thereof
12/19/2012CN101759806B Cytoplasm leader peptide (CTD)-containing human epidermal growth factor fusion protein (CTD-hEGF) prepared by using hydroxylamine cutting method and application thereof
12/19/2012CN101337992B Fusion protein of urokinase type plasminogen activator a chain and melittin and preparation thereof
12/18/2012US8334367 T2R taste receptors and genes encoding same
12/18/2012US8334260 sFRP and peptide motifs that interact with sFRP and methods of their use
12/18/2012CA2519059C Physiologically active polypeptide conjugate having prolonged in vivo half-life
12/18/2012CA2398064C 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
12/18/2012CA2385122C Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors
12/18/2012CA2345109C Receptor based antagonists and methods of making and using
12/13/2012WO2012170938A1 Compositions and methods for increasing serum half-life
12/13/2012WO2012169822A2 Fusion protein for suppressing cancer cell growth and suppressing vasculogenesis, and anticancer composition comprising same
12/13/2012WO2012126118A8 Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy
12/13/2012WO2012118323A3 Fusion protein comprising albumin and a retinol-binding protein
12/13/2012US20120316318 Polypeptide specifically binding to vascular endothelial growth factor, fusion protein including polypeptide, and methods therefor
12/13/2012US20120315321 Immunological methods and compositions for the treatment of alzheimer's disease
12/13/2012CA2838833A1 Pro-coagulant compounds and methods of use thereof
12/12/2012EP2531524A1 Fusion proteins comprising antigenic apob-100 protein fragments and a protein carrier, related compositions, methods and systems for treatment and/or prevention of atherosclerosis
12/12/2012CN1956998B Method for the purification of albumin conjugates
12/12/2012CN1810832B Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity
12/12/2012CN102816779A Novel tuberculosis vaccine and combined vaccine thereof
12/12/2012CN102816246A Human cytomegalo virus immunogen fusion protein as well as preparation method and usage thereof
12/12/2012CN102816245A Synthetic antibacterial protein group and preparation method and application thereof
12/12/2012CN102816244A Fusion protein of exendin-4 peptide and human serum albumin (HSA) and preparation method thereof
12/12/2012CN102816243A Application of rice transcription factor Os06g08400 genes
12/12/2012CN102816242A Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
12/12/2012CN102816241A Albumin fusion proteins
12/12/2012CN102816240A Fusion protein and fusion protein expression vector thereof
12/12/2012CN102816217A Chimeric, hybrid and tandem polypeptides of meningococcal nmb1870
12/12/2012CN102816216A Polypeptide capable of inducing granulation and application thereof
12/12/2012CN102816215A Smallish polypeptide capable of inhibiting HIV and medicinal use thereof
12/12/2012CN102816214A Artificial transcription factor of hepatitis B virus (HBx) genes and application of artificial transcription factor
12/12/2012CN102813918A Porcine circovirus 2 type recombinant subunit vaccine and preparation method thereof
12/11/2012US8329885 Nucleic acid encoding a T2R taste receptor
12/11/2012US8329862 Cell-killing peptide derived from the C-terminus of NOXA protein
12/11/2012US8329657 Fn14/TRAIL fusion proteins and method of treating cancer
12/11/2012CA2661042C Agents for blood-brain barrier delivery
12/06/2012WO2012165927A2 Secretory fusion protein for target tracking
12/06/2012WO2012165737A1 Cell-penetrating fusion protein for regenerating or proliferating stem cell
12/06/2012WO2012164320A1 Biological system for the production of specifically biotinylated monoclonal antibodies
12/06/2012WO2012163289A1 Fusion protein comprising diphtheria toxin non-toxic mutant crm197 or fragment thereof
12/06/2012US20120309940 Glycosylated repeat-motif-molecule conjugates
12/06/2012US20120309936 Reducing the immunogenicity of fusion proteins
12/06/2012US20120309934 Intracelluar targeting bipodal peptide binder
12/06/2012US20120309694 Dual Chain Synthetic Heparin-Binding Growth Factor Analogs
12/06/2012US20120309684 Conjugates for delivery of biologically active compounds
12/06/2012US20120309028 Immunoassay standards and measurement of clinical biomarkers using intra-assay calibration standards
12/06/2012US20120308565 Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
12/06/2012CA2837472A1 Rationally-designed anti-mullerian inhibiting substance type ii receptor antibodies
12/05/2012EP2528938A2 Pro-angiogenic fragments of prominin-1 and uses thereof
12/05/2012CN102807622A Fusion protein capable of activating tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6) signal path in targeted mode, recombinant vector and application of recombinant vector
12/05/2012CN102807621A Fusion protein containing diphtheria toxin non-toxic mutant cross-reacting material 197 (CRM197) or segment thereof
12/05/2012CN102807620A Method for forming targeted chemotherapeutic agents for treating infectious and malignant diseases
12/05/2012CN102807608A Peptide sequences and compositions
12/05/2012CN102807602A Peptide and composition thereof for improving liver dysfunction
12/05/2012CN102321602B Applications of beta-lactamase in improving functional protein folding and preparation of fusion protein
12/05/2012CN101942021B Hepatitis C virus specific antigen and application thereof in serotype
12/05/2012CN101367869B Polypeptide for preventing, diagnosing and treating hepatitis E virus, and vaccine as diagnosis agent of the same
12/05/2012CN101189261B High affinity melan-A t cell receptors
12/05/2012CN101014626B Glycosylated immunoglobulin and immunoadhesin comprising the same
12/04/2012US8324353 Chimeric immunoreceptor useful in treating human gliomas
12/04/2012US8324169 VEGF-activated ligands
12/04/2012US8323962 Molecules with extended half-lives, compositions and uses thereof
12/04/2012CA2400868C Anti-egfrviii scfvs with improved cytotoxicity and yield, immunotoxins based thereon, and methods of use thereof
11/2012
11/29/2012WO2012161372A1 Double-target antibody fused with a peptide and use of same
11/29/2012WO2012161227A1 Nucleic acid construct, nucleic acid-protein complex, and use thereof
11/29/2012WO2012159550A1 Fgfr-fc fusion protein and use thereof
11/29/2012WO2012159548A1 Fusion protein for antagonizing angiogenesis inducible factors and uses thereof
11/29/2012WO2012116076A3 Constructs that allow for detection and quantitation of membrane proteins
11/29/2012WO2012106670A8 Expandable liquid volume in an led bulb
11/29/2012WO2012093833A3 Genome engineering via designed tal effector nucleases
11/29/2012WO2012078741A3 Novel fungal esterases
11/29/2012US20120304336 Chloroplast transit peptides and methods of their use
11/29/2012US20120302737 Coiled coil and/or tether containing protein complexes and uses thereof
11/29/2012US20120302511 Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer
11/29/2012US20120301930 Bio-engineered multi-enzyme complexes comprising xylanases and uses thereof
11/29/2012US20120301921 Compositions and methods of treating disease with fgfr fusion proteins
11/29/2012US20120301496 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
11/29/2012US20120301494 Proteolysis-resistant capsid of chimeric hepatitis e virus as an oral delivery vector
11/29/2012US20120301493 Applications of the protein muns and the derivates thereof
11/29/2012US20120301483 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c
11/29/2012US20120301465 Compositions and methods to immunize against hepatitis c virus
11/29/2012DE112010004582T5 Optimierte Endonukleasen und Anwendungen davon Optimized endonucleases and applications thereof
11/29/2012CA2837170A1 Modular transport platform for targeted delivery of therapeutic agents
11/29/2012CA2837169A1 Multivalent and monovalent multispecific complexes and their uses
11/29/2012CA2834589A1 Method for preparing fc-containing polypeptides having improved properties
11/29/2012CA2834584A1 Fgfr-fc fusion protein and use thereof
11/29/2012CA2831161A1 Fusion protein for antagonizing angiogenesis inducible factors and uses thereof
11/28/2012EP2527437A1 Novel anti-CD98 antibody
11/28/2012CN102796752A Application of pronucleus-derived ubiquitin-like molecules
11/28/2012CN102796201A Erythropoietin mimetic peptide (EMP)-human serum albumin (HSA) fusion protein and preparation method thereof
11/28/2012CN102796200A Hybrid peptide bursin adjuvant and preparation method and application thereof
11/28/2012CN102796199A Fusion protein mutant of anti-cluster of differetiation (CD3) antibody Fv segment and interleukin 3, method for preparing fusion protein mutant and application of fusion protein mutant
11/28/2012CN102796198A Fusion protein of anti-cluster of differetiation (CD3) antibody Fv segment and interleukin 3, method for preparing fusion protein and application of fusion protein
11/28/2012CN102796197A Human serum albumin-granulocyte colony stimulating factor (HAS-GCSF) mutant and preparation method thereof
1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... 295